[HTML][HTML] Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing
JC Kim, PC Zuzarte, T Murphy, M Chan-Seng-Yue… - Leukemia, 2020 - nature.com
Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies
characterized by the proliferation of myeloid cells blocked in their ability to differentiate …
characterized by the proliferation of myeloid cells blocked in their ability to differentiate …
Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing.
JC Kim, PC Zuzarte, T Murphy, M Chan-Seng-Yue… - Leukemia, 2019 - europepmc.org
Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies
characterized by the proliferation of myeloid cells blocked in their ability to differentiate …
characterized by the proliferation of myeloid cells blocked in their ability to differentiate …
[HTML][HTML] Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing
JC Kim, PC Zuzarte, T Murphy, M Chan-Seng-Yue… - Leukemia, 2020 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies
characterized by the proliferation of myeloid cells blocked in their ability to differentiate …
characterized by the proliferation of myeloid cells blocked in their ability to differentiate …
Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing
JC Kim, PC Zuzarte, T Murphy… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole
genome and transcriptome sequencing Cryptic genomic lesions in adverse-risk acute myeloid …
genome and transcriptome sequencing Cryptic genomic lesions in adverse-risk acute myeloid …
[PDF][PDF] Cryptic genomic lesions in adverse-risk acute myeloid leukemia identiied by integrated whole genome and transcriptome sequencing
JC Kim, PC Zuzarte, T Murphy, M Chan-Seng-Yue… - Leukemia, 2020 - scienceopen.com
Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies
characterized by the proliferation of myeloid cells blocked in their ability to differentiate …
characterized by the proliferation of myeloid cells blocked in their ability to differentiate …
[PDF][PDF] Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing.
JC Kim, PC Zuzarte, T Murphy, M Chan-Seng-Yue… - Leukemia, 2020 - escholarship.org
Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies
characterized by the proliferation of myeloid cells blocked in their ability to differentiate …
characterized by the proliferation of myeloid cells blocked in their ability to differentiate …
Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing.
JC Kim, PC Zuzarte, T Murphy, M Chan-Seng-Yue… - Leukemia, 2020 - go.gale.com
Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies
characterized by the proliferation of myeloid cells blocked in their ability to differentiate …
characterized by the proliferation of myeloid cells blocked in their ability to differentiate …
[引用][C] Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing
JC Kim, PC Zuzarte, T Murphy, M Chan-Seng-Yue… - Leukemia, 2019 - cir.nii.ac.jp
Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated
whole genome and transcriptome sequencing | CiNii Research CiNii 国立情報学研究所 学術 …
whole genome and transcriptome sequencing | CiNii Research CiNii 国立情報学研究所 学術 …